GenMark Diagnostics, Inc. provided revenue guidance for the fourth quarter and full year ended December 31, 2020. For the quarter, total revenue for the fourth quarter of 2020 is expected to be approximately $50 million, representing an increase of 84% over the fourth quarter of 2019. ePlex revenue for the fourth quarter of 2020 is expected to be approximately $45 million, an increase of 138% over the fourth quarter of 2019. For the year, total revenue for 2020 is expected to be approximately $171 million, representing an increase of approximately 95% over 2019, ePlex® revenue for the full year 2020 is expected to be approximately $152 million, an increase of 155% over 2019.